Gainers
- Molecular Templates (NASDAQ:MTEM) stock increased by 96.6% to $0.64 during Thursday's pre-market session. The market value of their outstanding shares is at $4.2 million.
- Klotho Neurosciences (NASDAQ:KLTO) stock increased by 21.26% to $0.68. The market value of their outstanding shares is at $14.4 million.
- Healthcare Triangle (NASDAQ:HCTI) shares rose 17.07% to $0.48. The company's market cap stands at $2.7 million.
- HCW Biologics (NASDAQ:HCWB) stock increased by 16.66% to $0.7. The company's market cap stands at $26.4 million.
- IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 14.28% to $1.4. The company's market cap stands at $2.4 million.
- Baird Medical Investment (NASDAQ:BDMD) stock rose 11.34% to $3.63. The market value of their outstanding shares is at $128.6 million.
Losers
- Biodexa Pharmaceuticals (NASDAQ:BDRX) stock declined by 26.0% to $6.22 during Thursday's pre-market session. The company's market cap stands at $90.3 million.
- 180 Life Sciences (NASDAQ:ATNF) shares decreased by 20.25% to $5.16. The company's market cap stands at $5.2 million.
- Virpax Pharmaceuticals (NASDAQ:VRPX) stock fell 16.81% to $0.48. The company's market cap stands at $2.3 million.
- Carmell (NASDAQ:CTCX) shares fell 15.96% to $0.53. The company's market cap stands at $11.0 million.
- Quoin Pharmaceuticals (NASDAQ:QNRX) stock decreased by 13.89% to $0.68. The market value of their outstanding shares is at $2.7 million.
- Elevance Health (NYSE:ELV) stock decreased by 12.47% to $435.0. The company's market cap stands at $100.8 billion. As per the news, the Q3 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BDMDBaird Medical Investment Holdings Ltd
$1.40-4.76%
BDRXBiodexa Pharmaceuticals PLC
$4.44-1.99%
ELVElevance Health Inc
$338.26-%
HCTIHealthcare Triangle Inc
$2.260.89%
HCWBHCW Biologics Inc
$2.12-0.12%
KLTOKlotho Neurosciences Inc
$0.4750-0.04%
QNRXQuoin Pharmaceuticals Ltd
$20.50-5.75%
VRPXVirpax Pharmaceuticals Inc
$0.0210-96.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
